What is the price target for 1SRPT stock?
33 analysts have analysed 1SRPT.MI and the average price target is 26.4 EUR. This implies a price increase of 39.7% is expected in the next year compared to the current price of 18.9.
SAREPTA THERAPEUTICS INC (1SRPT.MI) Forecast, Price Target & Analyst Ratings
BIT:1SRPT • US8036071004
Current stock price
18.9 EUR
+4.16 (+28.22%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SAREPTA THERAPEUTICS INC (1SRPT.MI).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $1.00
- Revenue Estimate
- 484.21M
Price Target Details & History
Consensus Price Target and Range
Mean target
€26.40
Upside
+ 39.70%
From current price of €18.90 to mean target of €26.40, Based on 33 analyst forecasts
Low
€4.31
Median
€17.42
High
€165.84
Price Target Revisions
1 Month
2.40%
3 Months
-3.07%
Price Target Summary
33 Wall Street analysts provided a forecast for the next 12 months for 1SRPT.MI. The average price target is 26.4 EUR. This implies a price increase of 39.7% is expected in the next year compared to the current price of 18.9.
The average price target has been revised downward by 3.07% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
68.48%
1SRPT.MI was analyzed by 33 analysts. The buy percentage consensus is at 68. So analysts seem to be have mildly positive about 1SRPT.MI.
In the previous month the buy percentage consensus was at a similar level.
1SRPT.MI was analyzed by 33 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $1.00
- Revenue Estimate
- 484.21M
- Revenue Q2Q
- -34.99%
- EPS Q2Q
- 121.76%
- Number of Analysts
- 24
Next Earnings Revisions
Revenue (1 Month)
25.57%
Revenue (3 Months)
19.11%
EPS (1 Month)
206.84%
EPS (3 Months)
134.17%
Next Earnings Summary
1SRPT.MI is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 1 EUR and the consensus revenue estimate is 484.21M EUR.
The next earnings revenue estimate has been revised upward by 19.11% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.243B 33.26% | 1.902B 52.97% | 2.198B 15.58% | 1.77B -19.48% | 1.469B -17.01% | 1.478B 0.61% | 1.538B 4.06% | 1.496B -2.73% | 1.438B -3.88% | 1.461B 1.60% | 1.538B 5.27% | |
| EBITDA YoY % growth | -223.427M 54.80% | 255.805M 214.49% | -447.951M -275.11% | 402.48M 189.85% | 121.39M -69.84% | 110.98M -8.58% | 153.91M 38.68% | 104.65M -32.01% | N/A | N/A | N/A | |
| EBIT YoY % growth | -267.824M 50.05% | 218.081M 181.43% | -492.472M -325.82% | 326.49M 166.30% | 195.59M -40.09% | 110.68M -43.41% | 160.8M 45.28% | 111.4M -30.72% | 13.822M -87.59% | -5.896M -142.66% | -26.096M -342.59% | |
| Operating Margin | -21.54% | 11.47% | -22.40% | 18.45% | 13.31% | 7.49% | 10.46% | 7.45% | 0.96% | -0.40% | -1.70% | |
| EPS YoY % growth | -6.12 23.79% | 2.28 137.25% | -6.65 -391.67% | 3.02 145.42% | 2.14 -29.13% | 1.83 -14.27% | 3.50 90.55% | 3.32 -5.10% | 3.57 7.59% | 3.69 3.36% | 3.93 6.63% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.00 121.76% | 0.67 -64.38% | 0.42 4,282.00% | 0.76 119.37% | 0.33 -66.88% | 0.65 -3.79% | 0.60 44.51% | 0.65 -14.23% |
| Revenue Q2Q % growth | 484.21M -34.99% | 444.65M -27.24% | 398.84M -0.13% | 442.68M -0.06% | 394.05M -18.62% | 405.06M -8.90% | 409.61M 2.70% | 417.45M -5.70% |
| EBITDA Q2Q % growth | 207.73M 171.53% | 80.105M -41.27% | 105.33M 546.11% | 118.81M 159.33% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 105.75M 135.20% | 74.468M -35.57% | 52.574M 183.61% | 116.18M 147.46% | 41.391M -60.86% | 74.889M 0.57% | 74.031M 40.81% | 90.329M -22.25% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
31.54%
EPS Next 5 Year
20.10%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-12.16%
Revenue Next 5 Year
-7.26%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
31.21%
EBIT Next 5 Year
17.55%
SAREPTA THERAPEUTICS INC / 1SRPT.MI Forecast FAQ
Can you provide the upcoming earnings date for SAREPTA THERAPEUTICS INC?
SAREPTA THERAPEUTICS INC (1SRPT.MI) will report earnings on 2026-05-04, after the market close.
What are the consensus estimates for 1SRPT stock next earnings?
The consensus EPS estimate for the next earnings of SAREPTA THERAPEUTICS INC (1SRPT.MI) is 1 EUR and the consensus revenue estimate is 484.21M EUR.
How do analysts rate SAREPTA THERAPEUTICS INC (1SRPT.MI)?
The consensus rating for SAREPTA THERAPEUTICS INC (1SRPT.MI) is 68.4848 / 100 . This indicates that analysts generally have a neutral outlook on the stock.